Ipneb
Ipneb contains Ipratropium Bromide, an anticholinergic (parasympatholytic) bronchodilator. It works by blocking muscarinic cholinergic receptors in the smooth muscles of the lungs, preventing acetylcholine-induced bronchoconstriction. This results in dilation of the airways, making breathing easier for patients suffering from obstructive airway diseases.
Dosage by Body Weight
For inhalation use only via a suitable nebulizer. Do not inject or swallow. The standard adult dose is 250 mcg to 500 mcg (1 to 2 ml) administered 3 to 4 times daily. For pediatric patients, the dosage must be carefully determined by a pediatrician based on age, severity of symptoms, and clinical response.
- Body Weight
- Below 5 kg
- Dose
- Not routinely recommended
- Frequency
- Use only if explicitly prescribed
- Tracking Notes
- Safety and efficacy in infants under 5 kg have not been established. Use strictly under specialist supervision.
- Body Weight
- 5-7 kg
- Dose
- 125 mcg (approx. 0.5 ml of 250 mcg/ml solution)
- Frequency
- Every 6 to 8 hours as needed
- Tracking Notes
- Dilute with sterile normal saline to a minimum volume of 2 ml before nebulization.
- Body Weight
- 8-10 kg
- Dose
- 125 mcg to 250 mcg (0.5 ml to 1 ml of 250 mcg/ml solution)
- Frequency
- Every 6 to 8 hours as needed
- Tracking Notes
- Monitor heart rate and clinical response closely during administration.
- Body Weight
- 11-15 kg
- Dose
- 250 mcg (1 ml of 250 mcg/ml solution)
- Frequency
- 3 times daily
- Tracking Notes
- Ensure the nebulizer mask fits properly to prevent the medication from entering the eyes.
- Body Weight
- 16-20 kg
- Dose
- 250 mcg (1 ml of 250 mcg/ml solution)
- Frequency
- 3 to 4 times daily
- Tracking Notes
- Adjust dosage and frequency only under the direct supervision of a healthcare professional.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not routinely recommended | Use only if explicitly prescribed | Safety and efficacy in infants under 5 kg have not been established. Use strictly under specialist supervision. |
| 5-7 kg | 125 mcg (approx. 0.5 ml of 250 mcg/ml solution) | Every 6 to 8 hours as needed | Dilute with sterile normal saline to a minimum volume of 2 ml before nebulization. |
| 8-10 kg | 125 mcg to 250 mcg (0.5 ml to 1 ml of 250 mcg/ml solution) | Every 6 to 8 hours as needed | Monitor heart rate and clinical response closely during administration. |
| 11-15 kg | 250 mcg (1 ml of 250 mcg/ml solution) | 3 times daily | Ensure the nebulizer mask fits properly to prevent the medication from entering the eyes. |
| 16-20 kg | 250 mcg (1 ml of 250 mcg/ml solution) | 3 to 4 times daily | Adjust dosage and frequency only under the direct supervision of a healthcare professional. |
Formulation
Purpose
Used for the management and prevention of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, as well as an add-on therapy in acute asthma exacerbations.
Generic Name
Ipratropium BromideScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.